A Venture in Africa: The Challenges of African Business

Slide Number 1\nSlide Number 2\nSlide Number 3\nSlide Number 4\nSlide Number 5\nSlide Number 6\nSlide Number 7\nSlide Number 8\nSlide Number 9\nSlide Number 10\nSlide Number 11\nSlide Number 12\nPerfusion SPECT Quantitation\nNuclear CardiologyMyocardial Perfusion Imaging\nNuclear CardiologyMyocardial Perfusion\nNuclear CardiologyMyocardial Perfusion\nNuclear CardiologyMyocardial Perfusion\nNuclear CardiologyMyocardial Perfusion\nNuclear CardiologyMyocardial Perfusion\nNuclear CardiologyMyocardial Perfusion\nNuclear CardiologyMyocardial Perfusion and Stress Test Modalities\nCalculating Target Heart Rates\nExercise Protocol\nAdenosine Protocol\nDipyridamole Protocol\nDobutamine Protocol\nGated Perfusion Cardiac SPECT Imaging\nGated Perfusion Cardiac SPECT bh Imaging\nIntrathoracic Kidney\nNuclear CardiologyMyocardial Viability\nNuclear CardiologyMyocardial Viability\nNuclear CardiologyMyocardial Viability\nSlide Number 33\nSlide Number 34\nFunction\nNuclear CardiologyRadionuclide Ventricular Function\nNuclear CardiologyRadionuclide Ventricular Function\nNuclear CardiologyRadionuclide Ventricular Function\nNuclear CardiologyRadionuclide Ventricular Function\nSlide Number 40\nSlide Number 41\nSlide Number 42\nGated Perfusion SPECT Parameters\nGated Perfusion SPECT Interpretation\nDefects vs Artifacts\nSlide Number 46\nSlide Number 47\nSlide Number 48\nSlide Number 49\nGated Perfusion SPECT Imaging rc\nGated Perfusion Cardiac SPECT Imaging\nGated Cardiac SPECT ks\nThe END